To determine whether disruption of the RUNX1/PTBP1 interaction differentially affected the LSC and non-LSC cells, we treated mouse CM+ leukemia cells with entinostat for 24 h, and examined glucose uptake in these populations. The gene discussed is RUNX1; the disease is leukemia.